Application 018868
- Type
- NDA
- Sponsor
- KALAPHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 20MG | No | No |
| 002 | FUROSEMIDE | FUROSEMIDE | TABLET;ORAL | 40MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N018868-001 | FUROSEMIDE | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | ||
| N018868-002 | FUROSEMIDE | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018868-001 | FUROSEMIDE | 20MG | TABLET / ORAL | 1983-06-28 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N018868-002 | FUROSEMIDE | 40MG | TABLET / ORAL | 1983-06-28 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | A-S Medication Solutions | ac64c926-88e9-453a-884c-72ec6a1c746a | 2025-10-15 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 3f3248cd-d62f-49ca-8788-f059e8facd91 | 2025-10-15 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | c81d313c-65a3-4fb5-b6cd-b1c1ec7dca03 | 2025-10-15 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 5d7eb469-2371-4abb-8f49-be1596f10f27 | 2025-10-15 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 85375079-a9f1-42d4-8e15-c1d31395b29d | 2025-10-15 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Aphena Pharma Solutions - Tennessee, LLC | 3f6529fb-1173-ada3-e063-6294a90a76cb | 2025-10-13 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Meitheal Pharmaceuticals Inc. | 3aadaca7-3661-4bfe-87f8-6368e4ab6536 | 2025-10-06 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Cardinal Health 107, LLC | d75ba8bd-9494-4306-8443-9c1a90992dd5 | 2025-10-03 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 6194face-c26c-46ed-bde7-1e29bfeabd88 | 2025-10-02 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Lasix | FUROSEMIDE | Validus Pharmaceuticals LLC | 2c9b4d8f-0770-482d-a9e6-9c616a440b1a | 2025-09-30 | Warnings, Adverse reactions | FUROSEMIDE |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 53c3f50f-57c6-441b-afea-ec43d7943d1a | 2025-09-29 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Coupler LLC | 3eed4bbf-7d0e-e852-e063-6394a90a85c2 | 2025-09-16 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 48d8f490-e9d1-4c95-ab2f-414d3f4a9df4 | 2025-08-18 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | c24489c3-65e0-44e3-a50a-8bb0672e8821 | 2025-08-15 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 52e75604-5766-40e8-a13a-8c449e06ebda | 2025-08-15 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 12137a90-fb35-45d7-8984-0b04793d3e34 | 2025-08-15 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| FUROSEMIDE | FUROSEMIDE | Aurobindo Pharma Limited | a504ee4b-3995-45f2-898c-91116dd81d19 | 2025-07-19 | Warnings, Adverse reactions | FUROSEMIDE FUROSEMIDE |
| Furosemide | FUROSEMIDE | PD-Rx Pharmaceuticals, Inc. | 3ba730ab-90d4-478a-80b3-1ea3edb03e4d | 2025-07-15 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | NorthStar Rx LLC | fc3194a3-7e75-4551-8334-4a5cc22d9f8b | 2025-07-07 | Boxed warning, Warnings, Adverse reactions | Furosemide FUROSEMIDE |
| Furosemide | FUROSEMIDE | Proficient Rx LP | 600ca175-be2b-4c43-b119-133ae21a5601 | 2025-07-01 | Warnings, Adverse reactions | Furosemide FUROSEMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.